Last $10.12 USD
Change Today +0.16 / 1.61%
Volume 397.6K
INO On Other Exchanges
Symbol
Exchange
NYSE Amex
Frankfurt
As of 8:04 PM 07/11/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Simon X. Benito

Director, Chairman of Audit Committee and Member of Compensation Committee, Inovio Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 17 board members in 2 different organizations across 2 different industries.

See Board Relationships
69$91,433

Background*

Mr. Simon X. Benito served as Executive Vice President of Merck-Medco Managed Care from 1994 to 1996. Mr. Benito held various positions at Merck & Co Inc. From 1974 to 1999, including Senior Vice President, Vaccine Division from 1996 to 1999 and Vice President of Merck Human Health, Japan from 1986 to 1993. Mr. Benito has been a Director of Inovio Pharmaceuticals, Inc since December 18, 2003. Mr. Benito has been a Director of DURECT Corporation since April 18, 2005. ...

Read Full Background

Corporate Headquarters*

Building 18
Blue Bell, Pennsylvania 19422

United States

Phone: 267-440-4200
Fax: 267-440-4242

Board Members Memberships*

2003-Present
Director, Chairman of Audit Committee and Member of Compensation Committee
2005-Present
Director, Chairman of Nominating & Corporate Governance Committee, Member of Audit Committee and Member of Compensation Committee

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

Total Annual Cash Compensation$72,000
Total Calculated Compensation$91,433
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
INO:US $10.12 USD +0.16

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Vijay B. Samant Chief Executive Officer, President, Acting Chief Financial Officer and Director
Vical Incorporated
$557.0K
Steven W. King Chief Executive Officer, President, Director, Chief Executive Officer of Avid Bioservices Inc and President of Avid Bioservices Inc
Peregrine Pharmaceuticals, Inc.
$445.8K
Mark R. Baker J.D.Chief Executive Officer, Director and Member of Science & Strategy Committee
Progenics Pharmaceuticals, Inc.
$535.6K
Eddie Gray Chief Executive Officer and Director
Dynavax Technologies Corporation
$533.3K
Jonathan J. Lewis M.D., Ph.D.Chief Executive Officer and Director
ZIOPHARM Oncology, Inc.
$600.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact INOVIO PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.